SCHEMBL29812596

SCHEMBL29812596

O=S(=O)(O)Oc1cccc(O)c1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ STS P08842 4/20 0.51
▸ CISD1 Q9NZ45 1/20 0.51
▸ CYP3A4 P08684 2/20 0.50
▸ CA2 P00918 2/20 0.47
▸ CA9 Q16790 2/20 0.47
▸ CA1 P00915 1/20 0.47
▸ CA12 O43570 1/20 0.44
▸ ALDH1A1 P00352 1/20 0.44
▸ LMNA P02545 1/20 0.44
▸ CA5A P35218 1/20 0.44
▸ HSD17B10 Q99714 1/20 0.44
▸ CA14 Q9ULX7 1/20 0.44
▸ CA5B Q9Y2D0 1/20 0.44
▸ GLA P06280 1/20 0.42
▸ GAA P10253 1/20 0.42
▸ TSHR P16473 1/20 0.41
▸ ESR1 P03372 3/20 0.41
▸ ESR2 Q92731 3/20 0.41
▸ POLB P06746 1/20 0.41
▸ LCK P06239 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1243178 1.00 STS (0.51) STSCISD1CYP3A4CA2CA9
Naphthalene SCHEMBL10357718 0.93 STS (0.50) STSCISD1CYP3A4CA2CA9
SCHEMBL30526132 0.93 STS (0.46) STSCISD1CYP3A4CA2CA9
SCHEMBL9664445 0.87 CA1 (0.60) STSCISD1CA2CA9CA1
Propionic Acid SCHEMBL28865642 0.87 CYP3A4 (0.47) STSCISD1CYP3A4LMNACA5A
SCHEMBL5664523 0.82 ALDH1A1 (0.54) STSCYP3A4CA2CA9CA1
SCHEMBL7336916 0.81 ALDH1A1 (0.55) STSCYP3A4ALDH1A1LMNAGAA
Phenol SCHEMBL10636657 0.81 CA1 (0.50) STSCISD1CA2CA9CA1
SCHEMBL28591681 0.80 CISD1 (0.54) STSCISD1CYP3A4CA2CA9
SCHEMBL6932640 0.79 STS (0.47) STSCYP3A4CA2CA9CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250162986-A1 Compounds and compositions for neurodegenerative diseases UNIVERSIDADE NOV A DE LISBOA (PT) 2025-05-22 — — US disclosed
EP-4482483-A1 COMPOUNDS AND COMPOSITIONS FOR NEURODEGENERATIVE DISEASES UNIVERSIDADE NOVA DE LISBOA (PT) 2025-01-01 — — EP disclosed
CN-118742304-A Compounds and compositions for neurodegenerative diseases 里斯本新大学 2024-10-01 — — CN disclosed
WO-2023156983-A1 COMPOUNDS AND COMPOSITIONS FOR NEURODEGENERATIVE DISEASES UNIVERSIDADE NOVA DE LISBOA (PT) 2023-08-24 — — WO disclosed
EP-4230201-A1 COMPOSITION FOR TREATING NEURODEGENERATIVE DISEASES UNIVERSIDADE NOVA DE LISBOA (PT) 2023-08-23 — — EP disclosed
CN-114786497-A Beverage paste 雀巢产品有限公司 2022-07-22 — — CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250162986-A1 Compounds and compositions for neurodegenerative diseases CLN6, HTT, SNCA STS 4034/4885CISD1 2185/4885CYP3A4 4863/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback